Department of Oral Biology, University of Nebraska Medical Center, Lincoln, NE 68583; and Nebraska Center for Virology, University of Nebraska Medical Center, Lincoln, NE 68583
J Immunol. 2020 Oct 15;205(8):1981-1989. doi: 10.4049/jimmunol.2000462.
Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3). Consequently, most viruses that infect vertebrates encode proteins that interfere with IRF3 activation. This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens. Moreover, key regulatory pathways that control IRF3 are discussed. Besides viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in anticancer therapies involving DNA damage agents. A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases. In contrast, unregulated IRF3 activity is clearly not beneficial, considering it is implicated in certain interferonopathies, in which heightened IRF3 activity leads to IFN-β-induced disease. Therefore, IRF3 is involved largely in maintaining health but sometimes contributing to disease.
抗病毒免疫需要一系列关键的细胞蛋白,包括干扰素调节因子 3(IRF3)。因此,大多数感染脊椎动物的病毒都编码干扰 IRF3 激活的蛋白。本综述描述了与 IRF3 激活相关的细胞途径,以及人类病毒病原体靶向这些途径的位置。此外,还讨论了控制 IRF3 的关键调节途径。除了病毒感染,IRF3 还参与抵抗某些细菌感染、抗肿瘤免疫以及涉及 DNA 损伤剂的抗肿瘤治疗。最近的一项发现表明,IRF3 对于涉及抗肿瘤免疫和 T 细胞自身免疫性疾病的 T 细胞效应功能是必需的。相比之下,不受调节的 IRF3 活性显然没有益处,因为它与某些干扰素病有关,其中增强的 IRF3 活性导致 IFN-β 诱导的疾病。因此,IRF3 主要参与维持健康,但有时也会导致疾病。